CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Sarcura GmbH is creating a machine platform for the industrial manufacturing of personalized cell therapies, such as CAR-T therapies. The project aims to significantly increase production capacity while ensuring safety and cost-effectiveness through advanced microfluidic and automation technologies.
Sarcura GmbH, an Austrian deep-tech company founded in November 2019, will develop and market a machine platform for the industrial GMP manufacturing of personalised cell therapeutics, such as CAR-T therapies.We will contribute to scale the global cell therapy manufacturing capacity of these lifesaving treatments from currently thousands of doses per year to hundreds of thousands of doses, cost effective and safe for all patients.
Sarcura envisions to transform existing manufacturing paradigms b…
SARCURA GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
